JN-RD SRL
JN-RD reported total assets of 67,834 € at the end of the 2025 financial year (annual accounts filed with the NBB on 14 Jul 2026).
The score of JN-RD shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +66 % Total assets +62 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
JN-RD's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 14 Jul 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 31 Dec 2023filed on 17 Jul 2024
- Year ended 31 Dec 2022filed on 09 Oct 2023
JN-RD's financial analysis
- Solvency99.2%sector median: 58.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of JN-RD
JN-RD's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0778.830.420
- VAT number
- BE0778830420
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 20 Dec 2021
- Registered office
- 4360 Oreye
- Latest accounts
- 2025 · filed on 14 Jul 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
JN-RD (SRL) has been based in Oreye since 2021, active in: research and experimental development on biotechnology. For 2025, it reports a net loss of 795 € and equity of 67,273 €; its revenue is not published. Its solvency stands at 99.2%, above the median of its sector (58.2%).
Companies similar to JN-RD
Companies in the same business, of comparable size and area, outside its group.
- CTTec Research and experimental development on natural sciences and engineering Menen · balance sheet 259,750 €
- Yagh Penn Consulting Research and experimental development on natural sciences and engineering Bertem · balance sheet 34,428 €
- LP Engineering Research and experimental development on natural sciences and engineering Liège · balance sheet 138,903 €
- Pxlence Research and experimental development on natural sciences and engineering Ghent · balance sheet 147,731 €
- Dr. Frank Chielens Algemene Geneeskunde Research and experimental development on natural sciences and engineering Ypres · balance sheet 68,508 €
- Consulting Claudine Demeyere Research and experimental development on natural sciences and engineering Dilbeek · balance sheet 66,460 €
- Sightera Biosciences Research and experimental development on natural sciences and engineering Heist-op-den-Berg · balance sheet 63,382 €
- DR. Roelandt R. Health Research and experimental development on natural sciences and engineering Affligem · balance sheet 75,195 €
Frequently asked questions about JN-RD
What is the revenue of JN-RD?
JN-RD files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of JN-RD?
In Belgium, the VAT number is the company number prefixed with BE: BE0778830420 for JN-RD, if the company is VAT-registered. Its company number (CBE) is 0778.830.420.
Where is the registered office of JN-RD?
According to the CBE register, the registered office of JN-RD is in 4360 Oreye.
What is the equity of JN-RD?
At the close of the 2025 financial year, the equity of JN-RD amounts to 67,273 €, a solvency of 99.2% of total assets.
Who manages JN-RD?
The register lists 1 active mandates at JN-RD. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of JN-RD
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →